Objective: Focal cortical dysplasia (FCD) is a major pathology in patients undergoing surgical resection to treat pharmacoresistant epilepsy. Magnetic resonance imaging (MRI) postprocessing methods may provide essential help for detection of FCD. In this study, we utilized surface-based MRI morphometry and machine learning for automated lesion detection in a mixed cohort of patients with FCD type II from 3 different epilepsy centers. Methods: Sixty-one patients with pharmacoresistant epilepsy and histologically proven FCD type II were included in the study. The patients had been evaluated at 3 different epilepsy centers using 3 different MRI scanners. T1-volumetric sequence was used for postprocessing. A normal database was constructed with 120 healthy controls. We also included 35 healthy test controls and 15 disease test controls with histologically confirmed hippocampal sclerosis to assess specificity. Features were calculated and incorporated into a nonlinear neural network classifier, which was trained to identify lesional cluster. We optimized the threshold of the output probability map from the classifier by performing receiver operating characteristic (ROC) analyses. Success of detection was defined by overlap between the final cluster and the manual labeling. Performance was evaluated using k-fold cross-validation. Results: The threshold of 0.9 showed optimal sensitivity of 73.7% and specificity of 90.0%. The area under the curve for the ROC analysis was 0.75, which suggests a discriminative classifier. Sensitivity and specificity were not significantly different for patients from different centers, suggesting robustness of performance. Correct detection rate was significantly lower in patients with initially normal MRI than patients with unequivocally positive MRI. Subgroup analysis showed
the size of the training group and normal control database impacted classifier performance. Significance: Automated surface-based MRI morphometry equipped with machine learning showed robust performance across cohorts from different centers and scanners. The proposed method may be a valuable tool to improve FCD detection in presurgical evaluation for patients with pharmacoresistant epilepsy.
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| INTRODUCTION
Focal cortical dysplasia (FCD) type II is a major cause of pharmacoresistant epilepsy in patients undergoing surgical resection. 1 Typical magnetic resonance imaging (MRI) features of FCD type II include cortical thickening, blurring of gray-white matter junction, hyperintense signal on T2 or fluid-attenuated inversion recovery (FLAIR) sequences, and the "transmantle sign." 2, 3 Despite improvements in MRI resolution, some FCD type II lesions are too subtle to be detected by conventional visual analysis of MRI scans, 4 especially when noninvasive data do not point to a specific brain region. Discovering a previously missed lesion can have practical clinical impact by refocusing the surgical hypothesis, and lead to improved postoperative seizure outcomes. Postoperative seizure outcomes of patients with positive MRI are significantly better than those with negative MRI. 1 MRI postprocessing methods have been used to improve detection of FCD lesions. [5] [6] [7] [8] Our previous studies used morphometric analysis program (MAP), a voxel-based morphometry postprocessing method, which showed favorable results in detecting FCD. 9 Although very practical and robust to implement, voxel-based morphometry methods have some inherent limitations. They do not contain spatial relationships across the cortical surface, and any errors in registration can result in missing subtle lesions. 10 Additionally, reaffirmation by an experienced MAP reader or a neuroradiologist is still necessary to confirm the MAP results as per the previous studies 8, 9, 11 ; therefore, the yield and diagnostic confidence can depend on the reader's experience. To overcome some of these inherent weaknesses and further increase yield, a multivariate surface-based morphometry (SBM) approach may be beneficial. Recently, a few studies have reported multivariate SBM approaches combined with machine learning, with high accuracy for automated FCD detection in adult and pediatric patients (some had negative MRI by visual analyses). [12] [13] [14] However, the previous studies were all based on single centers, using a small cohort of patients with histologically confirmed or radiologically defined FCD, [12] [13] [14] and only 1 study assessed the false-positive rate in healthy controls. 12 To test the potential clinical value of any MRI postprocessing method, it is necessary to evaluate its robustness in a large dataset from different epilepsy centers using different MRI scanners. Herein, to test the diagnostic value of SBM and machine learning in patients with histologically proven FCD type II, we chose a mixed cohort from different epilepsy centers using different 3T MRI scanners. Additionally, receiver operating characteristic (ROC) analysis was performed to obtain the optimal threshold for the classifier output probability maps for automated lesion detection.
| MATERIALS AND METHODS

| Patient and normal control selection
Patients with pharmacoresistant epilepsy and histologically proven FCD type II from 3 different epilepsy centers were included in the study ( Trio, respectively). The normal database used for intersubject normalization was constructed using scans from 120 normal controls obtained from 4 different scanners. To assess specificity, we additionally included 2 test groups: (1) a healthy test group of 35 healthy subjects free of neurological disease; and (2) a disease test group of 15 patients with histopathologically confirmed hippocampal sclerosis and no temporal lobe FCD, who became seizure-free at 1 year following temporal lobectomy. For subgroup analysis, patients' MRI scans were classified as "MRI negative" (no remarkable abnormalities) or "MRI positive" by official radiology report. This study was approved by the institutional review board ethical guidelines of 3 hospitals (SAHZU, BTH, and CCF).
| MRI acquisition
MRI scans from SAHZU were performed on a 3T scanner (MR750, GE Healthcare) including a 3-dimensional (3D) T1 sagittal brain volume imaging sequence (repetition time Patients from BTH were scanned on a 3T Siemens Verio scanner including a 3D T1 sagittal magnetization prepared rapid gradient echo sequence (MPRAGE; TR = 1900 milliseconds, TE = 2.53 milliseconds, TI = 900 milliseconds, flip angle = 12°, slice thickness = 1 mm, no gap, matrix = 256 9 256, voxel size = 0.98 9 0.98 9 1 mm 3 ).
MRI scans from CCF were performed on a 3T Siemens Trio scanner including 3D T1 coronal MPRAGE (TR = 1860 milliseconds, TE = 3.4 milliseconds, TI = 1100 milliseconds, flip angle = 10°, slice thickness = 0.94 mm, no gap, matrix = 256 9 256, isotropic voxels = 0.94 mm). Normal controls and healthy test groups were included from SAHZU, CCF, and the Pediatric Imaging, Neurocognition, and Genetics Study (PING) in which MRI was performed on nine 3T scanners from 3 manufacturers (Siemens, GE, and Philips Medical, Andover, MA, USA), including the ones matching the patient scanners above. Detailed parameters are available on the PING website (http://ping.chd.ucsd.edu/).
| Cortical reconstruction
We used standard processes in FreeSurfer software v5.3 (http://surfer.nmr.mgh.harvard.edu/) for cortical reconstruction. [15] [16] [17] In brief, the processing involves (1) segmentation of white matter, (2) tessellation of the gray/white matter boundary, (3) inflation of the folded surface tessellation, and (4) automatic correction of topological defects. These steps have been described in detail elsewhere. 14 Reconstruction results of each subject were inspected visually, and any inaccuracies due to imaging artifacts were manually corrected.
| Lesion labels
The lesion masks were created manually in FreeSurfer, on the T1-weighted volumetric sequence, informed by postoperative MRI, FLAIR, and T2-weighted images (so that it is possible to create lesion masks for the cases initially thought to be MRI-negative by report). The lesion masks were then registered onto the cortical surface reconstructions. Each vertex in the training dataset was given 1 of 2 response values: lesional (1) if within the lesion mask, or normal (0) if outside of the lesion mask.
| Measures of morphological and intensity features
Six cortical features were acquired at each vertex of the 3D cortical reconstruction: cortical thickness, gray-white matter intensity contrast, curvature, sulcal depth, "doughnut" maps, and local cortical deformation (LCD). 14 Cortical thickness was calculated as follows. First, for each point on the white matter surface, the shortest distance to the pial surface was measured. Second, the shortest distance from each point on the pial surface to the white matter surface was computed. Cortical thickness at each vertex was computed as the average of the two values. 15 Gray-white matter intensity contrast was estimated by calculating the ratio of the gray matter signal intensity to the white matter signal intensity. 18 The gray and white matter signal intensities were sampled at a distance of 30% of the cortical thickness above the gray-white boundary and 1 mm below the graywhite boundary, respectively. Compared to healthy cortex, lesions with blurring of the gray-white matter boundary were expected to have low gray-white matter intensity contrast values. Mean curvature was measured as 1/r, where r is the radius of an inscribed circle and is equal to the average of the principal curvatures k1 and k2. 19 Sulcal depth was calculated by the dot product of the movement vector of the cortical surface during inflation. Shallow gyral areas of the brain move inward during inflation and have a negative value, whereas deep sulcal areas move outward and have a positive value. 14 Doughnut maps were assessed by measuring cortical thickness and gray-white matter intensity within a 6-mm-radius circle and within the doughnut, where the circle was centered on a vertex on the inflated surface and the doughnut was a surrounding region around the circle. 14 LCD was computed by the sum of intrinsic curvature within a 25-mm-radius ring (gray circle). 14 For every individual, cortical thickness, gray-white matter intensity contrast, and doughnut maps were smoothed using a 10-mm full width at half maximum Gaussian kernel, and then these features underwent 2 normalization procedures:
(1) within-subject z scoring and (2) between-subject z scoring by the population of 120 controls. All feature maps were registered to an average space (fsaverage_sym) that had an identical number of vertices for each hemisphere. For cortical thickness, gray-white matter intensity contrast, and LCD, interhemispheric asymmetry was calculated. 
| Evaluation of effectiveness of individual morphological features
The effectiveness of all the features was evaluated individually for each patient, and then for the entire cohort, by comparing kernel density plots of feature values within the lesion mask and the contralateral, homotopic healthy cortex.
| Machine learning classification and validation
Automated lesion detection was performed using an artificial neural network classifier implemented in MATLAB R2015b (MathWorks, Natick, MA, USA). The classifier was trained using all the aforementioned morphological and intensity features, as well as their corresponding interhemispheric asymmetry. Separate neural networks were also trained using individual features to evaluate the discriminatory value of each feature. A k-fold cross-validation strategy (k = 5) was used to validate the performance of the classifier. The top 5% vertices were identified and grouped into neighbor-connected clusters. The final cluster is considered as the highest mean probability value. In addition, a threshold was set (and tested in the next section with ROC analysis) so that the vertices with values above threshold were identified as lesional, and vertices with values below threshold were considered normal. Successful detection was defined by overlap between the final cluster (classifier output) and the manual label.
| ROC analysis
We varied the threshold values of the classifier output probability map to evaluate the sensitivity and specificity of the classifier. Any degree of overlap between the final cluster and manual lesion label was defined as correctly detected. The percentage of overlap is calculated by (number of overlapping vertices between the final cluster and the manual lesion label / total number of vertices in the final cluster) 9 100%. Sensitivity was calculated as the proportion of patients in whom the final cluster overlapped with the manual lesion label. Specificity was defined as the proportion of the subjects/patients in the healthy/disease test group who had no suprathreshold clusters. Youden index was calculated to get the optimal threshold (Youden index = sensitivity + specificity À 1). The area under the ROC was calculated to further quantify the performance of the classifier.
| Factors impacting classifier performance
Three factors were additionally tested to evaluate their effects on classifier performance: number of training cases, size of normal control database, and scanner type.
First, to assess the effect of the number of training cases, patients form SAHZU, BTH, and CCF were defined as separate training groups (11 patients, 16 patients, and 34 patients, respectively). Keeping all the other factors the same, the classifier was trained on the 3 patient groups separately, and then performance was evaluated.
Second, to evaluate the influence of the size of the normal database used for intersubject normalization of features, 120 normal controls were divided into 3 groups (SAHZU, 22 controls; CCF, 24 controls; and PING, 74 controls). Keeping all the other factors the same, the classifier was normalized by the 3 control groups separately, and then performance was evaluated.
Third, to test the role of scanner type, patients form SAHZU and CCF were normalized by SAHZU and CCF normal controls, respectively. Keeping all the other factors the same, performance was evaluated. We could not include patients from BTH in this analysis, because no normal scans were acquired from the scanner used in BTH.
| Statistical analysis
Descriptive statistics were used for each variable. If continuous variables (age, age at seizure onset, disease duration, sensitivity, specificity) were normally distributed, 2-sample t tests or 1-way analysis of variance was used. If not,
| RESULTS
| Patient demographics and clinical information
A total of 61 pharmacoresistant epilepsy patients with histologically proven FCD type II from 3 epilepsy centers (11 patients from SAHZU, 16 patients from BTH, 34 patients from CCF) were included (32 males, 33 children, mean age AE standard deviation [SD] = 20.43 AE 13.36 years). A total of 17 patients (27.9%) were MRI-negative by initial radiology report; in all of the 17 patients, subtle FCD lesions were identified at the patient management conference, which was aided by multimodal localization from semiology, electroencephalography (EEG), positron emission tomography, single photon emission computed tomography, and magnetic source imaging. Seizure freedom was achieved in 72.1% 1 year after surgery. Detailed profiles of patients, control subjects, and test subjects can be found in Table 1 .
| ROC analyses
The value with which the output probability map from the neural network was thresholded had a marked effect on classifier sensitivity and specificity (Table 2) . ROC analysis showed optimal overall performance at a threshold of 0.9, where sensitivity of the whole group was 73.7% and specificity was 90.0% (91.4% specificity in the healthy test group and 86.7% specificity in the disease test group). No statistically significant difference was seen in the specificity of the healthy test group versus the disease test group across the analysis of factors impacting classifier performance. Hence, we combined the healthy test group and disease test group into one group in the following analysis. The area under the curve for the ROC analysis was 0.75, which suggested a good discriminative classifier (Figure 1) . Figure 2 shows examples of successful detection. For the 45 patients with correctly identified lesions at the optimal threshold of 0.9, the mean percentage of overlap was 88.8% (SD = 22.9%, range = 1.6%-100%).
We further analyzed the 16 patients in whom the classifier did not correctly identify the lesions. In 8 patients the classifier did not output a probability map at the threshold of 0.9; that is, the results were negative. For the other 8 patients, the lesion in 1 patient was detected as the 5th cluster, and in 7 patients their lesions were not detected in any of the top 5 clusters. 
| Subgroup analyses
Sensitivity at the optimal threshold (0.9) showed similar results among 3 different centers (P = .990), at 72.7% for SAHZU, 75% for BTH, 73.5% for CCF, respectively. In the pediatric group (≤18 years old), the sensitivity was 69.7% (23 of 33), which was lower than the sensitivity of the adult group (78.5%, 22/28) but did not reach statistical significance (P = .562). Additionally, for the 44 MRI-positive patients, the detected clusters colocalized with the manual lesion in 36, yielding a sensitivity of 81.8%; for the 17 MRI-negative patients, a significantly lower proportion of the lesions were correctly detected (9/17, 52.9%, P = .048).
| Effectiveness of morphological features
As shown in Figure 3 , correct classification was largely based on gray-white matter intensity contrast, LCD, and cortical thickness, which showed the most grouplevel difference as compared to the normal control group. Figure 4 shows an example of successful detection, with illustration of all the features used for classification by the neural network classifier. In this particular case, thickness and gray-white matter intensity contrast features were the most helpful for lesion detection.
| Impact of the number of training cases
When patients from SAHZU, BTH, and CCF were used separately as training group, sensitivity was 54.5%, 75.0%, and 61.7%, respectively; specificity was 76.0%, 60.0%, and 86.0%, respectively. Optimal thresholds were at 0.98 for all 3 groups.
| Impact of the size of normal databases
When patient feature maps were normalized by smaller number of controls, that is, SAHZU, CCF, and PING
T A B L E 2 Sensitivity and specificity analyses at different thresholds in controls (normal test controls and disease test controls) and patients
showing the optimal threshold at 0. 
| Evaluation of the role of scannerspecific normal database
When the training group (patients from SAHZU and CCF) was normalized by its corresponding SAHZU and CCF normal controls, sensitivity was 57.8% and specificity was 78.0% based on the best threshold (0.9). identify putative lesion locations can be essential in these situations. Our retrospective study reveals the usefulness of a surface-based postprocessing and machine learning method in automatically detecting FCD type II lesions (73.7% sensitivity), while maintaining a low probability of false positives (90.0% specificity). The robustness of this methodology was seen by similar performances based on MRI datasets from 3 different centers using 3 different 3T MRI scanners.
| DISCUSSION
| Contribution to literature
Recently, Hong et al used a surface-based method coupled with a multivariate approach that showed a high sensitivity (14 of 19, 74%) in automatic classifying FCD type II lesions in adult patients with MRI-negative epilepsy. 12 No lesional vertices were identified in healthy and disease controls (patients with temporal lobe epilepsy), demonstrating excellent specificity. 12 In the study by Ahmed et al, who
reported another surface-based method, 13 14 of 24 MRInegative patients with histologically proven FCD were correctly and automatically identified. In both studies, only a small group of adult patients were studied and pediatric patients were not included. Moreover, no differentiation
Example patient showing measures generated by the surface-based morphometry approach in the parietal lobe. Note the multifocal appearance of each individual feature map. Information from each individual feature map was integrated by machine learning to generate a final cluster showing excellent concordance with expert labeling. Gray-white matter intensity measures blurring at the gray-white boundary; local cortical deformation (LCD) measures folding complexity; doughnut thickness measures local thickness variability; doughnut intensity measures local intensity variability at the gray-white boundary; interhemispheric gray-white matter intensity asymmetry measures the difference of bihemispheric blurring at the gray-white boundary; interhemispheric LCD asymmetry measures the difference of bihemispheric folding complexity; interhemispheric doughnut thickness measures the difference of bihemispheric local thickness variability; interhemispheric doughnut intensity measures the difference of bihemispheric local intensity variability at the gray-white boundary. FLAIR, fluid-attenuated inversion recovery; T1w, T1-weighted between the FCD subtypes was provided in the latter study. Adler et al delineated the SBM and neural network methods used in this current study, 14 and reported a successful detection rate of 73% in 22 pediatric patients with radiological diagnosis of FCD; however, specificity could not be tested. In the present study, we evaluated the diagnostic value of an adapted version of the methods by Adler et al 14 in a large group of patients with histologically proven FCD type II including both children and adults. By systematically investigating the effects of classifier thresholds on sensitivity and specificity, ROC analysis was performed to identify an optimal classifier threshold (0.9). Based on this threshold, our methods showed high sensitivity of 73.7% in patients with FCD type II, while maintaining a high specificity (90.0%); both results were similar to previous studies. [12] [13] [14] Moreover, our study tested the robustness of the methods on scans from different epilepsy centers and different MRI scanners. Subgroup analysis showed similarly high sensitivity among 3 different epilepsy centers, and there was no statistically significant difference between children and adults. Overall, our findings provide evidence that the fully automated SBM and machine learning approach could offer a substantial gain of FCD detection in the presurgical evaluation for pharmacoresistant patients. The demonstrated robustness is key to the clinical application of our methods.
| Size of the training group and normal control database
Our results showed the sensitivity and specificity was largely influenced by the size of the training group of patients and normal control database. The lower the number of patients included in the training group, the lower sensitivity and specificity tended to be. This is intuitive, because the classifier performance should improve as it learns idiosyncratic features in each training case. Similarly, the lower the number of normal controls included, the lower sensitivity and specificity tended to be. A larger normal control database would bring more normally distributed vertex feature values with lower standard deviations, which would likely help improve the accuracy of identifying abnormal vertices. These data highlight the importance of setting up a reasonably sized normal database and training database before clinical application of the methods.
| Role of scanner-specific normal database
When we used a scanner-specific normal database for the patients, the sensitivity was lower than when using the average normal database. When using a scanner-specific normal database, one would typically expect increased sensitivity and specificity. We speculate that our findings are due to the reduced number of training cases and reduced size of the normal database when the scanners needed to be matched, which masked the benefits brought by having the same scanner. This finding suggests that one should not be discouraged by not having a scanner-specific normal database before starting to use the proposed methods. A large combined training group and normal database, made publicly available, may be used instead. 11 
| Effectiveness of feature maps
In line with the previous study by Adler et al, 14 gray-white matter intensity contrast, LCD, and cortical thickness were more sensitive to detect FCD than other features. These results can be explained by blurring of the gray-white matter junction, gyration shape, and cortical thickness being typical MRI characteristics of FCD type II. 2, 3 Notably, multifocal appearance of individual features does not preclude the machine learning algorithm to successfully detect the lesion, as exemplified in Figure 4 .
| MRI-negative cases
Additionally, about 30% of patients in our study were MRI-negative by initial visual inspection, but the lesions were picked up at the multimodal patient management conference by an experienced team of experts; this team setup is not always available elsewhere. Our current data showed good sensitivity (52.9%) in this group of patients where the MRI was negative by initial visual inspection, suggesting that the use of type II lesions that are MRI-positive (obvious lesions) to train the classifier did benefit detection of the lesions that are initially not visually detected (subtle lesions), although with a lower sensitivity. It remains to be tested whether the more challenging type I lesions can be effectively detected with the current methods and training set. Given that type I and type II FCD share some common radiological characteristics but not all, 20 significant method development is likely needed. This is further complicated by lesion labels, used as the gold standard for lesional vertices, being difficult to create with type I FCD. Even on pathological examination, previous studies showed low interrater agreement on the existence and subtype classification of type I FCD. 21 
| False-positive findings
In the present study, one challenge was the presence of positive clusters in normal test controls and extralesional clusters in patients (false positives). For the 3 healthy test controls in whom abnormal clusters were detected, 2 were located in the same region (right inferior temporal), and the other was located in the left mesial frontal lobe. For the 2 disease test controls who had false-positive clusters, both clusters were located in the temporal lobe ipsilateral to the hippocampal sclerosis. In the 8 patients with FCD type II where clusters outside of the manual lesion masks were detected, 5 were located in the contralateral hemisphere, and 3 were detected in the ipsilateral hemisphere but distant from the known lesions. The following factors could cause the existence of false positives: (1) errors could be made due to registration inaccuracy, motion artifact, or bias field artifact; (2) frequent seizures could result in subtle abnormalities (eg, atrophy) that may be difficult to distinguish from developmental aberrations 22 ; and (3) structurally abnormal but dormant lesions were not uncommonly seen in epileptic brains. [23] [24] [25] [26] [27] Thus, the findings of the postprocessing methods should always be interpreted in conjunction with electroclinical characteristics. Future studies incorporating intracranial EEG could be used to determine whether there are abnormal electrophysiological characteristics associated with these "false-positive" regions.
| LIMITATIONS AND FUTURE DIRECTIONS
This study demonstrates the ability of automated tools to aid in the detection of focal cortical dysplasias. One limitation with the current study is that it is not ideally suited to assess the extent to which the lesions are correctly delineated. Accurate delineation of lesions would be invaluable to presurgical planning. In some patients, the histopathological changes may extend beyond visible MRI changes used to outline the lesions; in others, the surgical resection that guided manual lesion delineation might exceed the lesion extent. Thus, we acknowledge that there is subjectivity and the potential for error in the manual lesion delineations. Due to the absence of a ground truth for each lesion label, it is impossible to assess the extent to which discrepancies between manual and automated segmentations are due to errors in the former or the latter. Careful validation with a cohort where comprehensive postsurgical histopathological analysis and coregistration with preoperative MRI would be required to assess the extent to which the automated method is correctly identifying the lesion borders. We did not use FLAIR data as a multivariate input, because of the unavailability of FLAIR data in our control subjects. Patients whose lesions only exhibit subtle signal change on FLAIR images may therefore have false-negative results. Further sensitivity and specificity can be achieved by incorporating 3D FLAIR scans or normalized 2D FLAIR scans, as FLAIR intensity was reported to be the most discriminatory feature for detecting lesional vertices. 14, 28 It would be important for future studies to compare the effectiveness of various postprocessing methods reported in the literature through a multicenter data-sharing platform where FCD cases and control cases can be shared and tested. This will allow comparison of yields, sensitivity, and specificity of the various postprocessing methods, as well as lesion characteristics. To this end, quantitative MRI maps that are more specific to tissue microstructure and can provide neuroimaging markers of tissue properties such as myelin, water, and iron content would be useful. 29, 30 Future work incorporating features from quantitative MRI maps under the framework of machine learning is likely to improve automated lesion detection particularly in the case of subtle, MRI-negative lesions. 20 
| CONCLUSION
We demonstrated the usefulness of a surface-based MRI morphometry with machine learning using the largest-todate cohort of pharmacoresistant patients with FCD type II, showing robust performance across cohorts from different centers and scanners. This freely available method can be a valuable tool to improve noninvasive presurgical evaluation for patients with pharmacoresistant epilepsy.
